Evidence map›Paper›PMID 31129588›Full record

ArticleBMJ open2019

Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual patient data meta-analysis protocol.

Shirley Pei-Chun Yu, Manuela L Ferreira, Marienke van Middelkoop, Sita M A Bierma-Zeinstra, Weiya Zhang, Leticia A Deveza, David J Hunter

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shirley Pei-Chun YuDepartment of Rheumatology, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Manuela L FerreiraDepartment of Rheumatology, Institute of Bone and Joint Research, University of Sydney, St Leonards, New South Wales, Australia.
Marienke van MiddelkoopErasmus MC University Medical Center, Rotterdam, The Netherlands.
Sita M A Bierma-ZeinstraDepartment of General Practice, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Weiya ZhangDivision of Academic Rheumatology, University of Nottingham, Nottingham, Nottingham, UK.
Leticia A DevezaDepartment of Rheumatology, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
David J HunterDepartment of Rheumatology, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-3197-752X

Funding

Arthritis Research UK
6 · The paper itself

Abstract

introductionOsteoarthritis (OA) is a highly prevalent and disabling condition with limited safe and effective treatment options. Intra-articular therapies are increasingly being used, however whether the effect of these agents is due to active treatment or placebo remains unclear. As the placebo response can be attributed to multiple factors, assessment of the placebo response using individual patient data (IPD) meta-analysis will give insight into the different modifiers of response to placebo. The aim of this IPD meta-analysis is to investigate the predictors of placebo response in intra-articular injection trials in OA. IPD meta-analysis is considered to be superior to conventional meta-analysis, as it combines multiple trial data, facilitates the standardisation of analyses across different studies and allows measuring derivation of the desired information. METHOD AND ANALYSIS: A systematic literature search will be conducted for randomised clinical trials comparing corticosteroid and viscosupplementation/hyaluronic acid intra-articular injections with placebo for knee and hip OA. Pubmed (Medline), EMBASE, Web of Science, Cochrane Central and SCOPUS will be searched from inception to September 2018. Corresponding authors of the original trials will be contacted to obtain IPD. Risk of bias will be assessed using the Cochrane Collaboration's tool. The primary outcome will be change in pain from baseline. Secondary outcomes will be change in function and patient's global assessment. Potential predictors of placebo response assessed will include patient's characteristics, pain mechanism characteristics, radiographic severity, pain severity, intervention characteristics and trial design characteristics. A multilevel logistic regression analyses will be applied. Results will be reported using the Preferred Reporting Items for Systematic review and Meta-Analysis -IPD guidelines. ETHICS AND DISSEMINATION: This study does not include identifiable data and ethical approval was obtained by the original investigators. Results of the IPD meta-analysis will be disseminated for publication in peer-reviewed journals and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42018095188.

Indexed as

Adrenal Cortex HormonesHumansHyaluronic AcidInjections, Intra-ArticularMeta-Analysis as TopicOsteoarthritis, HipOsteoarthritis, KneePlacebo EffectTreatment OutcomeViscosupplementationViscosupplementsAdrenal Cortex HormonesHyaluronic AcidViscosupplementsindividual patient data meta-analysisintra-articular therapyosteoarthritisplacebo response

Identifiers

PMID31129588
PMCPMC6537977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.